Illumina (ILMN) is a publicly traded Healthcare sector company. As of August 19, 2026, ILMN trades at $189.76 with a market cap of $29.16B and a P/E ratio of 34.85. ILMN moved -2.56% today. Year to date, ILMN is +43.56%; over the trailing twelve months it is +87.30%. Its 52-week range spans $68.70 to $207.00. Analyst consensus is buy with an average price target of $194.93. Rallies surfaces ILMN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies AI research for ILMN combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
| Metric | Value |
|---|---|
| Price | $189.76 |
| Market Cap | $29.16B |
| P/E Ratio | 34.85 |
| EPS | $5.40 |
| Dividend Yield | 0.00% |
| 52-Week High | $207.00 |
| 52-Week Low | $68.70 |
| Volume | 977.45K |
| Avg Volume | 0 |
| Revenue (TTM) | $4.49B |
| Net Income | $824.00M |
| Gross Margin | 66.39% |
15 analysts cover ILMN: 0 strong buy, 7 buy, 5 hold, 3 sell, 0 strong sell. Consensus rating is buy. Average price target: $194.93.